When physicians should switch from W2 to private practice ownership

The decision to leave W2 employment for practice ownership is the largest single financial decision most physicians will ever face that is not a house — and unlike a house, it comes with no inspection, no appraisal standard, and a seller who is also your future partner. The stakes are real on both sides: a well-structured buy-in can add $100,000 to $200,000 per year of income plus six figures of additional retirement-plan space, while a badly priced one can lock a physician into five years of below-market pay to purchase goodwill that evaporates when the senior partners retire.

This article takes the decision seriously in both directions. Ownership is not the automatic graduation from employment that practice brokers describe, and employment is not the trap that ownership evangelists describe. It is a trade — floor for ceiling, simplicity for control — and the right answer depends on numbers you can actually obtain before signing.

The core trade: income floor versus income ceiling

A W2 physician sells variance. The hospital absorbs payer-mix shifts, staffing crises, rent increases, and bad quarters; the physician receives a contracted salary, a 401(k) or 403(b) with a match, malpractice coverage, and the right to go home without thinking about accounts receivable. The price of that insurance is the spread between what the physician collects for the system and what the system pays the physician — a spread that is real, permanent, and rarely shown to the person generating it.

An owner buys that variance back. Partner compensation in a healthy private group typically runs meaningfully above employed compensation for the same clinical work, because the owner keeps the spread — professional collections net of overhead, plus a share of whatever the practice earns beyond physician labor. But the floor is gone. When a major payer cuts rates, when two medical assistants quit in the same month, when the building lease renews at 30% more, that is now partially your income statement.

Buy-in mechanics: what you are actually purchasing

A buy-in has up to three components, and pricing discipline differs for each.

Hard assets and working capital. Equipment, build-out, supplies, and the cash cushion the practice operates on. This is the most defensible component — auditable, depreciable, real.

Accounts receivable. Collections already earned but not yet received. Legitimate to buy into, but check the aging: AR over 120 days old in a medical practice is mostly fiction and should be valued accordingly.

Goodwill. The premium above tangible value — the referral patterns, the brand, the schedule full of established patients. This is where buy-ins go wrong. Goodwill is worth something in a practice with durable referral streams and partners a decade from retirement; it is worth very little if the senior partner whose name fills the schedule retires eighteen months after cashing your check.

Sanity checks before any price negotiation:

• Payback period. Divide the total buy-in (plus any income you forgo on the partnership track) by the annual income increase partnership actually delivers. Healthy deals commonly pay back in roughly two to four years. A deal that takes seven years to pay back is a job with a cover charge.
• Symmetry. The buy-out formula for departing partners should mirror the buy-in formula for arriving ones. If retiring partners exit at a richer multiple than you enter at, you are funding their retirement, not buying equity.
• The documents, not the pitch. Three years of practice financial statements, the partnership or operating agreement, current payer contracts' general health, and every existing partner's compensation methodology. An independent review — a healthcare CPA and an attorney who did not draft the agreement — typically costs $5,000 to $15,000 against a six-figure decision.

The due-diligence file: what to demand before talking price

"Three years of financials" is the headline, but the file you actually need is more specific. Before any number is negotiated, you should be holding:

• Three years of profit-and-loss statements and balance sheets, plus year-to-date. Look for trend, not snapshot: is overhead creeping up faster than collections? Did last year's partner income depend on a one-time event — a payer settlement, an equipment sale, a retiring partner's wind-down?
• An AR aging report, bucketed 0–30, 31–60, 61–90, 91–120, and 120+ days. If you are buying into AR, each bucket gets a different discount, and the 120+ bucket gets close to zero.
• Payer mix by revenue, not by patient count. A practice drawing more than 30–40% of revenue from a single commercial payer has a concentration risk that one contract renegotiation can realize. Heavy Medicare dependence means revenue moves with the fee schedule, which you do not control.
• Every current partner's compensation methodology and actual amounts for three years. Not the recruiting pitch — the formula (productivity split, equal share, hybrid) and the real W-2/K-1 figures it produced, including the median partner, not the founder's best year.
• The buy-sell agreement, complete. What triggers a buy-out (death, disability, retirement, voluntary departure, termination for cause), the valuation formula for each trigger, the payment terms, and whether the obligation is insurance-funded. An unfunded buy-out obligation to a retiring senior partner is a liability you are buying a share of.
• Ancillary entity documents. If the lab, imaging, ASC, or real estate sits in separate entities, each has its own ownership ledger and may carry its own buy-in. "Partner" in the practice does not automatically mean partner in the building.

A group that produces this file promptly is telling you something. So is a group that does not.

Ancillary revenue: the real ownership upside, with an asterisk

Clinical labor alone rarely justifies a large buy-in, because your labor moves with you. What cannot move with you is the practice's non-physician revenue: in-office lab and imaging, an ambulatory surgery center interest, physical therapy, real estate the practice owns and rents to itself, pathology, infusion. Ancillaries are how a partner earning $460,000 differs from an employee earning $320,000 doing identical clinical work — the partner owns slices of several small businesses that the employee merely feeds.

Ask precisely how ancillary income is distributed (equally per partner, by ownership share, by utilization) and how federal self-referral rules constrain each stream — these arrangements live inside specific legal exceptions, and structures that drift outside them put the income at risk.

The management tax

Ownership is paid partly in money and partly in meetings. Budget for it honestly: hiring and terminations, payer contract negotiations, EHR decisions, compliance, the lease, the partner who is chronically under-producing. In most groups this runs several unpaid hours per week, concentrated unpredictably, and it is governance — you can delegate operations to a practice manager but not the responsibility.

Some physicians find this energizing; the practice becomes a second professional identity. Others discover that every administrative hour is deducted from either clinical revenue or family time, and that they sold their evenings for income they did not need. Be honest about which physician you are before the buy-in makes the question expensive.

The retirement-plan upside: ownership's quietest advantage

This is the benefit employed physicians most often miss when comparing offers. A W2 physician's tax-advantaged space is largely fixed by the employer: the $24,500 elective deferral, whatever match exists, perhaps a 457(b) at a hospital. An owner designs the plan.

A practice can sponsor a 401(k) with profit sharing reaching the full §415(c) limit of $72,000 per partner in 2026 (employee plus employer dollars). On top of that, a group with strong cash flow and older partners can layer a cash balance / defined benefit plan, which for physicians in their 50s can permit additional tax-deductible contributions of $100,000 to $200,000+ per year depending on age and plan design. For a partner in the 35% federal bracket, moving $150,000 of income from "taxed now" to "deducted now, taxed in retirement" is worth roughly $50,000 per year in deferred federal tax alone — a recurring benefit that can rival the headline income difference.

A worked five-year comparison

Assumptions stated explicitly so you can argue with them — and you should, with the actual numbers from an actual deal.

The physician: mid-career, productive, choosing between staying employed and joining a private group's partnership track.

Path A — W2: $320,000 salary, flat in real terms, with a $13,000 annual employer retirement contribution. Stable, fully benefited.

Path B — ownership: two-year partnership track at $280,000, then partnership. Buy-in of $400,000 paid $100,000 per year over four years (treated here as cash cost; financing changes timing, not totals). Partner compensation $460,000 including ancillary distributions, beginning year three.

Run the same table with less favorable but common inputs — a $460,000 expectation that turns out to be $400,000, a payer cut in year four, a senior partner's early retirement deflating the goodwill you purchased — and crossover drifts toward year eight or nine. Run it with an ASC interest or practice-owned real estate and crossover arrives earlier and steeper. The framework is the point; the inputs must be the real ones.

Your tax life changes the day the K-1 arrives

Becoming a partner usually means your income stops arriving as a W-2 with taxes withheld and starts arriving as a K-1 share of practice profit with nothing withheld at all. Three practical consequences, none optional.

Quarterly estimated taxes are now your job. No employer is remitting anything on your behalf. A partner earning $460,000 owes the IRS four estimated payments a year, and the safe-harbor rule — pay at least 110% of last year's total tax to avoid underpayment penalties — is the planning anchor, especially in year one when last year's tax was computed on a smaller W-2. Open a separate tax account and fund it every distribution; partners who discover the estimated-tax obligation in April fund it with a loan.

Self-employment tax replaces the employee-side simplicity. Depending on the entity structure, some or all of your K-1 income carries self-employment tax, and the employer half of FICA that the hospital used to pay quietly is now inside your own economics. This is a structure question for the CPA, not a reason to avoid ownership — but it belongs in the five-year table as a real cost.

Do not count on the QBI deduction. The Section 199A qualified business income deduction looks like a 20% gift to pass-through owners, but physicians are a "specified service trade or business," and the deduction phases out for SSTB owners above a taxable-income threshold — $403,500 married filing jointly for 2026, with nothing left by $553,500. The deduction itself is now permanent law, and the 2026 rules widened the phase-out range, so a partner at $460,000 may salvage a partial deduction depending on taxable income after retirement-plan contributions. Treat any QBI benefit as a bonus your CPA models, not a number you bank in the comparison.

The offsetting good news: as an owner you control deductible expenses an employee cannot touch — and the retirement-plan design space in the previous section is the largest tax lever of all.

When staying W2 is the right answer

Ownership is the wrong move, full stop, when any of these hold:

• The deal fails the math. Payback beyond five years, asymmetric buy-out terms, or financials they will not share.
• You carry PSLF balances with significant progress. Private practice is almost never a qualifying employer. A physician 70 payments into the 120 required should price abandoned forgiveness — often six figures — directly into the comparison.
• Your horizon is short or uncertain. A buy-in amortizes over a career in one place. If a spouse's career, fellowship plans, or honest restlessness make a five-year commitment doubtful, the floor is worth keeping.
• The specialty's economics are consolidating against small groups. In some markets and specialties, payer leverage and hospital acquisition have compressed the owner surplus to the point where the ceiling sits barely above the floor. Three years of the group's actual margins will tell you.
• You hate the meetings. Sincerely a sufficient reason. A physician who resents governance will be a bad partner and an unhappy owner, at any income.

Common questions

Should I finance the buy-in or pay cash?

Most groups offer either a payroll-deduction structure or bank financing (several banks have physician practice-loan programs). Financing preserves liquidity during the lowest-income years of the track, at interest cost. What matters more than the financing choice is the total: model the all-in cost — buy-in plus forgone track income plus interest — as the true price of the partnership.

How is the buy-in taxed?

It depends on the structure — purchasing equity is generally not deductible, while compensation-reduction structures can shift some or all of the cost pre-tax. Structures vary widely and the difference can be worth tens of thousands of dollars — model both with a healthcare CPA before agreeing on a number, not after.

What income difference justifies ownership?

As a rough screen: if partner compensation exceeds your realistic W2 alternative by less than 20%, the buy-in, variance, and management hours rarely justify the switch on financial grounds alone. Above 30–40% — common where ancillaries are strong — the math usually favors ownership for any physician planning to stay seven or more years. Between those bands, the retirement-plan design space and your tolerance for governance decide it.

Does partnership-track time count for anything if I leave before partnership?

Usually not financially — that is precisely the risk of the track. Negotiate the track terms as carefully as the partnership terms: a defined track length (two years is common, longer deserves justification), objective partnership criteria in writing, and clarity on what happens to any pre-paid buy-in amounts if either side walks.

Can I keep moonlighting or 1099 income as a partner?

Often yes, but read the partnership agreement's outside-income and non-compete provisions; some agreements sweep outside clinical income into the practice. If you retain 1099 income, a solo 401(k) against it may add retirement space — coordinate the limits carefully, since elective deferrals are aggregated across plans even though §415(c) limits are per unrelated employer.

What to do next

1. Request three years of practice financials, the partnership agreement, and every partner's compensation methodology. Treat hesitation as data.
2. Build the five-year table above with the real numbers: actual track salary, actual buy-in and payment schedule, the median partner's actual W2-equivalent income — not the best year of the best partner.
3. Compute the payback period and check buy-in/buy-out symmetry before discussing price.
4. Price your PSLF position explicitly if you have one — remaining forgiveness belongs in the comparison as a real dollar figure.
5. Spend $5,000–$15,000 on an independent healthcare CPA and attorney review. It is the cheapest insurance in the entire transaction.
6. Decide the management-tax question honestly, ideally by asking the group's newest partner what their week actually looks like.

If you are weighing a specific partnership-track offer, the contract reading guide inside Attending Financial will walk the agreement clause by clause — compensation methodology, track terms, restrictive covenants — before you bring it to your attorney.